Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,244 public trials 1,186 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer

NCT00583830

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Birmingham Hematology and Oncology Associates, LLC Birmingham, Alabama, United States
  • Desert Hematology Oncology Medical Group, Inc. Rancho Mirage, California, United States
  • University of Colorado Health Sciences Center Aurora, Colorado, United States
  • Osceola Cancer Center Kissimmee, Florida, United States
View all 33 locations
View Trial Details
Completed

Optimization of Treatment of Advanced Nonsmall Cell Lung Cancer Using Radiotherapy and Chemotherapy

NCT00864331

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Instituto de Radiomedicine Santiago, Chile
  • Affiliated Hospital of Ning Xia Medical College, Department of Radiation Oncology Yinchuan, China
  • University of Zagreb Faculty of Medicine Zagreb, Croatia
  • Misr Oncology Center (MOC) Cairo, Egypt
View all 13 locations
View Trial Details
Completed

Cisplatin Plus Vinorelbine With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

NCT00017459

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Tower Hematology Oncology Medical Group Los Angeles, California, United States
  • Medical Oncology Internal Medicine Los Angeles, California, United States
  • Bay Area Tumor Institute Oakland, California, United States
  • Medical Oncology Care Associates Orange, California, United States
View all 42 locations
View Trial Details
Completed

Study of TRM-1(TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC)

NCT00092924

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • University of Colorado Cancer Center Denver, Colorado, United States
  • Rush Medical College Chicago, Illinois, United States
  • Duke Comprehensive Cancer Center Durham, North Carolina, United States
  • Sarah Cannon Cancer Center Nashville, Tennessee, United States
View Trial Details

Related conditions